Introduction
============

Murine coronavirus mouse hepatitis virus (MHV) is a member of the family *Coronaviridae*, which is a group of enveloped, single-stranded, and positive-sense RNA viruses. MHV utilizes its surface spike (S) glycoprotein to initiate infection by interacting with a specific cellular receptor ([@bib74]). This interaction triggers a conformational change of the spike, resulting in exposure of its fusogenic domain, which further triggers fusion between viral envelope and plasma membrane and subsequent release of the nucleocapsid into cytoplasm ([@bib51]). In some MHV strains, virus entry occurs following receptor-mediated endocytosis ([@bib54]). The precise process of virus uncoating is not clear, but is believed to involve dephosphorylation of the nucleocapsid (N) protein and dissociation of N protein from viral genomic RNA ([@bib37]). The incoming viral genomic RNA is then translated into the viral polymerase polyprotein of more than 800 kDa that is essential for subsequent viral replication and transcription.

MHV can infect rodents and cause hepatitis, nephritis, enteritis, and central nervous system (CNS) diseases ([@bib62], [@bib28]). In the CNS, MHV infection causes encephalitis and demyelination. Because the pathology of demyelination caused by MHV infection resembles those of multiple sclerosis (MS) seen in humans, MHV has been extensively used as an animal model for MS and other neurodegenerative diseases ([@bib42], [@bib29]). Following MHV infection, mice usually develop acute encephalitis and demyelination during the first week of infection ([@bib75]). Most of the viruses are cleared from the CNS at the end of the second week post-infection (p.i.). If the mice survive the acute phase, chronic demyelination then develops and reaches to a peak at around 30 days p.i. At this time, however, infectious virus can no longer be isolated but viral RNAs are still detectable in the CNS ([@bib22], [@bib1]). Viral RNA can persist in the CNS, especially in astrocytes, for an extended period of time ([@bib1], [@bib56], [@bib58]).

Astrocytes play important roles in supporting the nervous system and controlling the chemical and ionic environment of the CNS. Astrocytes can be stimulated to produce diverse pro-inflammatory molecules such as cytokines, chemokines, and nitric oxide ([@bib69], [@bib33], [@bib15]). It has been shown that MHV infection can induce the expression of transforming necrosis factor (TNF)-α, interleukin (IL)-6, matrix metalloproteinases, and inducible nitric oxide synthase (iNOS) in astrocytes ([@bib41], [@bib36], [@bib79], [@bib26]). Infection of astrocytes with MHV may thus modulate the development of the CNS pathology and alter the course of the disease. In vitro, MHV can persist in the DBT astrocytoma cell line, in the progenitor oligodendrocyte/astrocyte CG-4 cells and in a fibroblast 17Cl-1 cell line ([@bib13], [@bib47], [@bib48], [@bib61]). However, the precise mechanisms of viral persistence in animal CNS and in cultured cell lines are not known. Previous studies have suggested that alteration of receptor expression in DBT and 17Cl-1 cells by MHV infection may facilitate viral persistence ([@bib14], [@bib57], [@bib61]). In our previous analysis on cellular gene expression in MHV-infected DBT cells using the DNA microarray technology, we suggested that alterations of the expression of cellular genes, in addition to the receptor down-regulation, might play an important role in establishing persistent infection in DBT cells ([@bib8]).

One of such candidate cellular factors is the early growth regulator-1 (Egr-1). Egr-1 is also named as nerve growth factor induced-A (NGFI-A), zif268, TIS8, or Krox24, which is an immediate early gene, the prototype of a family of zinc-finger transcription factors ([@bib73], [@bib12], [@bib16], [@bib70], [@bib43]). Egr-1 can be rapidly induced by diverse stimuli, including growth factors, hormones, cytokines, neurotransmitters and injurious stimuli through different mitogen-activated protein kinases (MAPKs) pathways, including the extracellular signal-regulated kinase (ERK), c-Jun NH~2~-terminal kinase (JNK), and p38 MAPK pathways depending on the stimuli ([@bib66], [@bib10], [@bib11], [@bib45], [@bib53], [@bib32]). For example, Egr-1 gene expression is induced through ERK signal pathway by cytokines and growth factors, while it is induced via p38 and JNK pathways by stress treatment such as heat shock, sodium arsensite, ultraviolet, radiation, and anisomycin ([@bib60], [@bib47]). As a transcription factor, Egr-1 contains a DNA binding domain, which binds specifically to the consensus binding sequence GCG (T/G) GGGCG ([@bib10]). Egr-1 can induce the expression of a number of genes, such as platelet-derived growth factor (PDGF)-A and -B, macrophage colony-stimulating factor (M-CSF), TNF-α, IL-2, and intercellular adhesion molecule (ICAM)-1 ([@bib19], [@bib38], [@bib27], [@bib40], [@bib65], [@bib50]). All of these genes contain one or more Egr-1 consensus binding sites within their promoter regions. Thus, Egr-1 is involved in regulation of a variety of cellular processes, including cell proliferation, differentiation, neuronal plasticity, vascular wound response, and cancer progression ([@bib30], [@bib55], [@bib35], [@bib38], [@bib39]). For examples, it has been demonstrated that astrocyte growth is regulated by neuro-peptides through basic fibroblast growth factor and Egr-1 ([@bib34], [@bib6]); Egr-1 was significantly increased in prostate carcinoma and treatment with anti-Egr-1 anti-sense dramatically inhibited the prostate cancer progression, suggesting a role for Egr-1 in the development of prostate cancer ([@bib20], [@bib3], [@bib4]).

In the present study, we investigated the expression of Egr-1 in MHV-infected DBT cells, the signal pathways that induce Egr-1 expression, and the potential outcome of Egr-1 expression on cell survival and viral persistence. We found that both mRNA and protein levels of Egr-1 were significantly induced in DBT cells by MHV infection, which was mediated through the ERK signal pathway. Moreover, the ability of MHV strains to induce Egr-1 expression was correlated with their ability to cause persistent infection in the CNS. Our data may thus suggest a link between the induction of Egr-1 gene expression and the establishment of viral persistence in DBT cells. These findings may also provide insight into the mechanisms by which MHV establishes persistence in the DBT cells and in animal CNS.

Results
=======

Induction of the transcription factor Egr-1 expression in astrocytoma DBT cells by MHV infection
------------------------------------------------------------------------------------------------

In a previous study, we performed DNA microarray analysis to determine the alteration of cellular gene expression by MHV infection in DBT cells ([@bib8]). We found that the expression of a substantial number of genes was altered by MHV infection. Among them, the expression of the transcription factor Egr-1 was increased more than 9-fold (data not shown). To verify the microarray data, we used RT-PCR to directly determine the Egr-1 mRNA during the course of virus infection. DBT cells were infected with MHV-JHM strain at an m.o.i. of 5 or mock-infected. The intracellular RNAs were isolated at various time points p.i. cDNAs were synthesized by RT with a random primer and were amplified by PCR using a primer pair specific to Egr-1 or β-actin as an internal control. As shown in [Fig. 1](#fig1){ref-type="fig"}A, the cDNAs representing Egr-1 gene were not induced at 4 h p.i., but were dramatically increased (a 46-fold increase) at 8 h p.i., and peaked at 12 h p.i. At 16 h p.i., the level of Egr-1 mRNA appeared to decline. In contrast, the level of β-actin mRNA remained relatively constant from 4 to 16 h p.i. These results demonstrate that the expression of Egr-1 gene was induced by MHV infection at the transcriptional level, which confirmed the finding obtained from microarray analysis.Fig. 1Induction of transcription factor Egr-1 expression by MHV-JHM infection. DBT cells were infected with MHV-JHM strain at an m.o.i. of 5 or mock-infected. For mRNA detection (A), intracellular RNAs were isolated at various time points p.i. as indicated. RT-PCR was performed to detect the mRNAs of Egr-1 gene and β-actin, the latter of which was served as an internal control. The RT-PCR products were analyzed by electrophoresis on 2% agarose gel and visualized by staining with ethidium bromide. Images were taken with the digital camera (UVP). For protein detection (B), cells were lysed at various time points p.i. as indicated. Equal amounts of cell lysates were separated by polyacrylamide gel (9%) electrophoresis. Proteins were then transferred to nitrocellulose membranes and were detected with an Egr-1 antibody and enhanced chemiluminescence by Western blot analysis. An aliquot of an equal amount of cell lysates from each sample was used for analyzing the β-actin protein with the β-actin antibody as an internal control. The data are representative of three independent experiments. M, lysates from mock-infected cells; V, lysates from MHV-JHM-infected cells.

Next, Western blot was employed to detect Egr-1 protein. Following infection, DBT cells were harvested and lysed at various time points p.i. Immunoblotting with the anti-Egr-1 antibody or anti-β-actin antibody was performed. As expected, a significant increase (≈ 20-fold) in Egr-1 protein was detected in virus-infected cells at 8 and 12 h p.i. but not at 4 h p.i., as compared to those in mock-infected cells ([Fig. 1](#fig1){ref-type="fig"}B). Taken together, these data demonstrate that Egr-1 gene expression was significantly induced in DBT cells by MHV infection.

Both live and UV-inactivated MHVs were capable of inducing Egr-1 gene expression
--------------------------------------------------------------------------------

To determine whether the induction of Egr-1 expression requires viral replication, UV-irradiated virus was used in comparison with live virus infection. UV-irradiated virus can bind to cell receptors and penetrate into the cells, but is unable to replicate. DBT cells were infected with UV-irradiated virus or live virus, or mock-infected. Total intracellular RNAs were isolated at 8 and 12 h p.i. RT-PCR was performed to determine the expression of Egr-1 mRNA. As shown in [Fig. 2](#fig2){ref-type="fig"} , Egr-1 mRNA was induced by infection with the live virus at 8 and 12 h p.i. Although infection with UV-inactivated virus did not significantly induce Egr-1 expression at 8 h p.i., it did so by 12 h p.i. (≈ 20-fold increase as compared to mock-infected cells), indicating that virus replication is not absolutely required for Egr-1 induction. The data also suggest that virus entry alone is sufficient to induce Egr-1 expression, albeit with a low efficiency.Fig. 2Egr-1 mRNA expression was induced by both live and UV-irradiated viruses. DBT cells were infected with live or UV-irradiated MHV-JHM or mock-infected. Intracellular RNAs were isolated at 8 and 12 h p.i. RT-PCR was performed to detect Egr-1 mRNA. β-actin was used as an internal control. The RT-PCR products were analyzed by electrophoresis on 2% agarose gel and visualized by staining with ethedium bromide. Images were taken with the digital camera (UVP). The intensity of each band was quantified and the ratio of Egr-1 to β-actin for each sample was presented as E/A ratio. The data are representative of three independent experiments. M, RNAs from mock-infected cells; V, RNAs from MHV-JHM-infected cells; UV-V, RNAs from UV-irradiated MHV-JHM-infected cells.

The induction of Egr-1 was mediated by virus infection through the ERK signal pathway
-------------------------------------------------------------------------------------

It has been previously reported that both p38 and JNK MAPKs were activated in DBT cells infected with MHV-JHM during viral replication ([@bib2]). It has also been shown that ERK was activated in peritoneal exudative macrophages at a very early time point of infection (5 min p.i.) with MHV-3 ([@bib52]). As described in the introduction, Egr-1 can be induced by all three MAPK pathways. It was therefore interesting to determine whether MHV-induced Egr-1 gene expression was mediated through one or more of the three MAPK signaling pathways. To address this question, we determined the activation of Egr-1 by MHV infection following the treatment of cells with inhibitors specifically inhibiting one of the three MAPK pathways. UO126 is the inhibitor of the ERK pathway, whereas SB203580 and SP600125 are the inhibitors of p38 and JNK pathways, respectively ([@bib17], [@bib5], [@bib21]). DBT cells were treated with UO126 (25 μM or 50 μM), SB203580 (40 μM), SP600125 (40 μM), or DMSO (as a negative control) for 1 h prior to infection, during and throughout the infection. Cells were infected with MHV-JHM at an m.o.i. of 5 or mock-infected. Intracellular RNAs were harvested at 12 h p.i., and Egr-1 mRNAs were detected by RT-PCR. As shown in [Fig. 3](#fig3){ref-type="fig"}A, treatment of cells with UO126 at either concentration (25 μM or 50 μM) almost completely blocked the induction of Egr-1 by MHV infection. By contrast, treatment with SB203580 or SP600125 failed to block Egr-1 induction by MHV infection. To verify this finding, we used a new inhibitor, CI-1040, which has been shown to be even more specific and potent to the ERK pathway ([@bib63]). We found that treatment of DBT cells with CI-1040 (3--5 μM) blocked the induction of Egr-1 by MHV infection to a level similar to those treated with UO126 at 50 μM ([Fig. 3](#fig3){ref-type="fig"}B). We thus conclude that induction of Egr-1 gene expression by MHV infection was likely mediated through the MEK-ERK signal pathway.Fig. 3The induction of Egr-1 gene by MHV infection was mediated through the ERK signal pathway. (A) DBT cells were pre-treated with MEK inhibitor UO126 (I: 25 μM or II: 50 μM), JNK inhibitor SP600125 (40 μM), p38 inhibitor SB203580 (40 μM), or DMSO for 1 h prior to infection. These treated cells were then infected with MHV-JHM at an m.o.i. of 5 or mock-infected. At 12 h p.i., the intracellular RNAs were isolated and were subjected to RT with a random primer. cDNAs were amplified by PCR using the primer pair specific to Egr-1 or β-actin (as an internal control). The drugs were present in the medium throughout the 12 h period. The data are representative of three independent experiments. M, RNAs from mock-infected cells; V, RNAs from MHV-JHM infected cells. (B) As in panel A, except that the ERK1/2 inhibitor CI-1040 (CI-I: 3 μM; CI-II: 5 μM) was used and that the concentration of UO126 was 50 μM in this experiment.

Activation of the ERK signal pathway by MHV infection
-----------------------------------------------------

Although the above studies with MAPK inhibitors pointed out the involvement of ERK pathway in Egr-1 induction, it is not known whether the ERK pathway is actually activated by MHV infection. To provide direct evidence for the activation of the ERK pathway, we determined the phosphorylation status of ERK1 (p44) and ERK2 (p42) following MHV infection. Because it is well known that serum can stimulate ERK activation, DBT cells were subjected to serum-starvation for 24 h prior to virus infection. DBT cells were then infected with gradient-purified MHV-JHM at an m.o.i. of 5 or mock-infected. After 1 h binding at 4 °C, the viral inoculums were removed. Cells were fed with fresh medium without serum and were incubated at 37 °C. At various time points as indicated, cell lysates were prepared for determination of ERK1/2 phosphorylation by Western blot analysis. As shown in [Fig. 4](#fig4){ref-type="fig"} , although ERK1/2 phosphorylation was detected in both virus-infected and mock-infected cells at all time points p.i., the levels of phosphorylation were significantly higher in virus-infected cells than in mock-infected cells from 5 to 120 min p.i. Moreover, no increase in ERK1/2 phosphorylation was detected in virus-infected cells at 0 min p.i. Taken together, these data indicate that the ERK signal pathway was indeed specifically activated by MHV-JHM infection.Fig. 4Activation of ERK signaling pathway by MHV infection. DBT cells were infected with purified MHV-JHM at an m.o.i. of 5 or mock-infected. After 1 h binding at 4 °C, the viral inoculums were removed and fresh medium without serum were added to the plates. The cells were harvested and lysed following incubation at 37 °C for various time points p.i. as indicated. Equal amounts of cell lysates were separated by polyacrylamide gel (10%) electrophoresis. Proteins were then transferred to nitrocellulose membranes and were detected with an antibody specific for phosphorylated-forms of ERK1/2 (ERK1/2-P) and enhanced chemiluminescence by Western blot analysis. An aliquot of an equal amount of cell lysates from each sample was used for analyzing total ERK1/2 (ERK1/2-T) with an antibody specific for ERK1/2 as an internal control. The data are representative of three independent experiments. M, lysates from mock-infected cells; V, lysates from MHV-JHM-infected cells.

Over-expression of Egr-1 repressed BNip3 promoter activity
----------------------------------------------------------

We have demonstrated in a previous study that the expression level of the pro-apoptotic gene BNip3 was down-regulated by MHV infection ([@bib8]). A recent report showed that BNip3 gene expression was down-regulated by over-expression of Egr-1 in prostate cancer cells ([@bib71]). Therefore, it is of interest to determine whether the down-regulation of BNip3 in MHV-infected DBT cells is also mediated through the induction of the transcription factor Egr-1. First, we determined the BNip3 promoter activity by using the luciferase reporter assay ([@bib8]). We expressed Egr-1 protein transiently in DBT cells by cotransfecting pBS-CMV-Egr-1, which contains the Egr-1 ORF under the control of a CMV promoter, and pGL3-BNip3 reporter plasmid ([@bib7], [@bib8]). After 20 h post-transfection, cell lysates were harvested and luciferase activity determined. Results showed that transient cotransfection with an increased amount of Egr-1-expressing plasmid (ranging from 20 to 500 ng per well) exhibited an increased inhibitory effect on BNip3 promoter activity by 2 to 45% ([Fig. 5](#fig5){ref-type="fig"}A). This inhibition appeared to be specific for Egr-1 because cotransfection with the empty vector pBS-CMV (without expressing the Egr-1) did not have any effect on luciferase activity ([Fig. 5](#fig5){ref-type="fig"}A). The specific inhibitory effect of the expressed Egr-1 on pGL3-BNip3 reporter was further examined in a cotransfection experiment, in which pBS-CMV-Egr-1 or pBS-CMV and the pSV-β-gal reporter plasmid (which is under the control of an SV40 promoter) were cotransfected into DBT cells. At 24 h post-transfection, β-gal activity was determined. In stark contrast to the result for pGL3-BNip3 reporter ([Fig. 5](#fig5){ref-type="fig"}A), the β-gal activity was virtually unaffected by the expression of Egr-1 ([Fig. 5](#fig5){ref-type="fig"}B). Thus, over-expression of Egr-1 selectively inhibited BNip3 promoter activity.Fig. 5Inhibition of the BNip3 promoter activity by over-expression of Egr-1. (A) BNip3 promoter activity in transiently transfected cells. DBT cells were transiently cotransfected with the Egr-1 expression plasmid (pBS-CMV-Egr-1) or empty vector (pBS-CMV) at an amount of 0, 20, 100, or 500 ng per well and pGL3-BNip3 reporter plasmid at 500 ng per well. After 20 h post-transfection, cell lysates were harvested, and the luciferase activity was measured. The relative luciferase activity in pBS-CMV-Egr-1-expressing cells is indicated as percentage of the luciferase activity expressed from pBS-CMV-transfected cells, which was set as 100%. Data are the average of a triplicate experiment and are representative of 3 independent experiments. (B) Effect of Egr-1 on SV40 promoter activity. The experiments were performed exactly as in panel A except that the cotransfecting reporter plasmid is pSV-β-gal instead of pGL3-BNip3. (C) Stable expression of Egr-1 in DBT cells. DBT cells were transfected with the Egr-1 expression plasmid (pcDNA3-Egr1) or with empty vector (pcDNA3). Following selection with G418 for more than 1 month, two clones stably expressing Egr-1 were obtained. The expression levels of these two clones were determined by Western blot with an antibody specific to Egr-1. β-actin protein serves as an internal control. (D) BNip3 promoter activity in Egr-1-stable expressing cells. Equal numbers of cells from these two cloned cells or cells stably transfected with pcDNA3 empty vector were cotransfected with pGL3-BNip3 reporter plasmid and pSV-β-gal plasmid, the latter of which was used as a control for transfection efficiency. After 24 h post-transfection, the luciferase activity and β-gal activity were measured. The relative luciferase activity in Egr-1-expressing cells (Egr1-1 and Egr1-2) is indicated as percentage of the luciferase activity expressed from pcDNA3-transfected cells, which was set as 100%. The luciferase activity was normalized with β-gal activity. Data are the average of three independent experiments and error bars denote standard deviation.

To further confirm these results, we established cell lines that stably express Egr-1 protein. We tested two cell clones, which expressed different amounts of Egr-1 protein. Clone \#2, termed Egr-1--2, expressed higher level of Egr-1 protein than clone \#1, termed Egr-1--1, which expressed almost the same amount of Egr-1 protein as the cells stably transfected with the empty vector pcDNA3 plasmid ([Fig. 5](#fig5){ref-type="fig"}C). Equal numbers of these cloned cells were cotransfected with pGL3-BNip3 reporter plasmid and pSV-β-gal plasmid, the latter of which served as a control for transfection efficiency as well as for specificity. At 24 h post-transfection, luciferase and β-gal activities in the cells were determined, and the luciferase activity was normalized to β-gal activity, which was essentially unaffected by the cotransfection. As shown in [Fig. 5](#fig5){ref-type="fig"}D, BNip3 promoter activity was decreased approximately 45% in Egr-1--2 clone, while it decreased only 7% in Egr-1--1 clone as compared to those in vector-control cells (lane pcDNA3). These results demonstrate that over-expression of Egr-1 repressed the expression of the pro-apoptotic BNip3 gene, thus suggesting that the previously observed down-regulation of BNip3 expression in DBT cells by MHV-infection was likely mediated through up-regulation of Egr-1 expression.

Role of Egr-1 in virus propagation and cell survival
----------------------------------------------------

To establish the biological relevance of the Egr-1 induction, we used an siRNA specific to Egr-1 to knockdown Egr-1 in DBT cells. Cells were transfected with an Egr-1-siRNA or a non-specific EGFP-siRNA, the latter of which serves both as a negative control and for monitoring the transfection efficiency. At various times post-transfection, the protein level of Egr-1 was monitored by Western blot analysis. A representative result obtained at 60 h post-transfection is shown in [Fig. 6](#fig6){ref-type="fig"}A. In the absence of virus infection, the Egr-1 level was significantly lower in Egr-1-siRNA-transfected cells than in EGFP-siRNA-transfected cells, demonstrating the effectiveness and specificity of the Egr-1-siRNA. Similarly, Egr-1 expression was effectively blocked by Egr-1-siRNA but not by EGFP-siRNA even in the presence of virus infection. Egr-1 protein was much higher in virus-infected cells than in mock-infected cells when the cells were transfected with the EGFP-siRNA, further confirming that MHV infection induces Egr-1 expression. We then determined the effect of Egr-1 knockdown on virus propagation. Indeed, knockdown of Egr-1 expression by Egr-1-siRNA exhibited a detrimental effect on virus propagation, reducing the virus titer by approximately 2 log10 ([Fig. 6](#fig6){ref-type="fig"}B). Interestingly, apoptotic cells were increased in virus-infected, Egr-1 knockdown cells as compared to the control cells that were transfected with the EGFP-siRNA ([Fig. 6](#fig6){ref-type="fig"}C). Although the increase was statistically significant (*p*  = 0.037), the level of the increase was extremely low, which may result from a number of factors. For example, in siRNA-expressing cells, not only was Egr-1 much lower ([Fig. 6](#fig6){ref-type="fig"}A) but also was the virus replication ([Fig. 6](#fig6){ref-type="fig"}B). Thus, very low level of virus replication might not be able to induce robust apoptosis. Nevertheless, these results indicate that Egr-1 may play a role in virus replication and cell survival.Fig. 6Effect of Egr-1 knockdown on virus propagation and cell survival. (A) Effect of Egr-1-siRNA on Egr-1 expression. DBT cells were transfected with Egr-1-siRNA or EGFP-siRNA for 60 h, and then infected with MHV or mock-infected with PBS. Cells were lysed at 16 h p.i. and proteins were detected by Western blot with anti-Egr-1 or anti-β-actin antibodies (A). Virus titers were determined by virus plaque assay at 16 h p.i. and were expressed as mean ± standard deviation (SD) of three experiments (B). (C) Apoptosis was assessed by determining the apoptotic nuclei following propidium iodide staining, and was expressed as mean percentage of the cell population and SD of three experiments. Statistical analysis indicates significance between the Egr-1 knockdown cells and the control cells (*p* = 0.037).

Induction of Egr-1 gene expression by MHV infection was correlated with the abilities of the viruses to cause persistent infection
----------------------------------------------------------------------------------------------------------------------------------

Both MHV-JHM and MHV-A59 are demyelinating-positive strains and can cause persistent infection in the CNS of infected rodents, whereas MHV-2 is a non-demyelinating strain and does not cause persistent infection. To test the hypothesis in cell culture that cellular gene expression altered by MHV infection may contribute to the control of virus replication and persistence in CNS cells and consequently to viral pathogenicity, we determined whether MHV strains with distinctive pathogenic phenotypes have different abilities to induce Egr-1 expression. DBT cells were infected with different strains of MHV (including MHV-JHM, -A59 and MHV2) or mock-infected. Total intracellular RNAs were isolated at different time points p.i. as indicated, and the RNA level of Egr-1 gene was determined by RT-PCR. As shown in [Fig. 7](#fig7){ref-type="fig"}A, Egr-1 mRNA was induced (approximately 3 fold) by both MHV-JHM and MHV-A59 at 8, 12, and 16 h p.i., but not at 4 h p.i. In contrast, infection with MHV-2 failed to induce Egr-1 expression as compared to those of mock-infected cells (compare lanes 4, 8, 12, and 16 with lanes 1, 5, 9, and 13 in [Fig. 7](#fig7){ref-type="fig"}A). We also performed Western blot to detect the protein expression. As presented in [Fig. 7](#fig7){ref-type="fig"}B, Egr-1 protein was significantly increased in both JHM- and A59-infected cells (≈ 11- and 7-fold increase, respectively) but not in MHV-2-infected cells. These data provide evidence that correlates the ability of the MHV strains to induce Egr-1 expression with their ability to cause persistent infection in the CNS cells and demyelinating disease in the animal CNS.Fig. 7Differential induction of Egr-1 expression by different MHV strains. (A) Expression of Egr-1 mRNA. DBT cells were infected with different strains of MHVs (including MHV-JHM, A59 and MHV2) or mock-infected. Total intracellular RNAs were isolated at various time points p.i. as indicated. RT-PCR was performed to detect the Egr-1 mRNA. β-actin was used as an internal control. The RT-PCR products were analyzed by electrophoresis on 2% agarose gel and visualized by staining with ethedium bromide. Images were taken with the digital camera (UVP). Lanes 1, 5, 9, and 13: RNAs from mock-infected cells; Lanes 2, 6, 10, and 14: RNAs from cells infected with MHV-JHM; Lanes 3, 7, 11, and 15: RNAs from cells infected with MHV-A59; Lanes 4, 8, 12, and 16: RNAs from cells infected with MHV-2. The intensity of each band was quantified by densitometry (UVP), which is indicated as relative amount (rel. amt) shown beneath each lane. (B) Detection of Egr-1 protein. DBT cells were infected as in panel A. Cells were harvested and lysed at 12 h p.i. Equal amounts of the cell lysates were separated by polyacrylamide gel (9%) electrophoresis. Western blot was performed to detect Egr-1 and β-actin proteins by using an antibody specific to Egr-1 and β-actin, respectively. The intensity of each band was quantified and the relative quantity was expressed as a ratio of Egr-1 to β-actin (E/A ratio) for each sample.

Discussion
==========

In the present study, we have demonstrated that MHV infection of DBT cells induced the expression of transcription factor Egr-1 as determined by RT-PCR and Western blot. These results confirmed our previous findings obtained from DNA microarray analysis ([@bib8]). As an immediate-early gene, Egr-1 can be rapidly induced by a variety of stimuli, including virus infections. Indeed, in addition to MHV as found in this study, it has been shown that Egr-1 gene expression is induced by infections with diverse groups of viruses. For example, Egr-1 expression was induced in the brain tissue in experimental mice infected with Rabies virus and Borna disease virus (BDV), in a number of human cells infected with human foamy virus (HFV), in human T-cell leukemia virus type 1-(HTLV-1) or type 2 (HTLV-2)-transformed cell lines, in B-lymphocytes infected with Epstein--Barr virus (EBV), and in Bc-2 cells latently infected with Kaposi\'s sarcoma-associated herpesvirus (KSHV) ([@bib23], [@bib72], [@bib9], [@bib76], [@bib66]).

How is the Egr-1 expression induced by virus infection? In HTLV-transformed cells, it appears that the Tax protein is responsible for the induction of Egr-1 expression ([@bib24]). As a transactivator, Tax can interact with the transcription factor CREB/ATF and serum response factors (SRFs) ([@bib68], [@bib25]). These factors in turn interact with the CREB/ATF response element (CRE) and serum response element (SRE), respectively, on the promoter of Egr-1, thus activating the expression of Egr-1 ([@bib24], [@bib59]). In the case of MHV-infected cells, we demonstrated the activation of ERK by MHV infection and the inhibition of Egr-1 expression by the MEK1/2 inhibitors ([Fig. 4](#fig4){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}). Our results thus suggest that the induction of Egr-1 expression upon MHV infection is likely mediated through the ERK signaling pathway. It is well established that the activation of ERK can activate its downstream transcription factor Elk, which then interacts with SRFs and activates a number of immediate-early genes whose promoters contain an SRE. Therefore, we postulate that the induction of Egr-1 by MHV infection might follow the ERK1/2 → Elk → SRFs → Egr-1 pathway. The upstream signal(s) that activates ERK1/2 has not been determined in this study although the inhibitor that we used to block ERK activation acts on the upstream kinase MEK1/2. Nevertheless, our data suggest that the upstream signal(s) most likely resides within or in the vicinity of the cytoplasm membranes, which is activated during virus entry. There are two pieces of evidence supporting this interpretation. First, infection with UV-inactivated virus was still capable of inducing Egr-1 transcription ([Fig. 2](#fig2){ref-type="fig"}). Second, ERK1/2 was activated within 5 min upon virus entry and during the first 2 h p.i. ([Fig. 4](#fig4){ref-type="fig"}). Although live virus is a stronger inducer for Egr-1 expression than UV-inactivated virus, ERK1/2 activation was no longer detected at 3 h following infection (data not shown). This suggests that although virus replication may play a role in the induction of Egr-1 activation, the predominant signal that activates Egr-1 expression is likely triggered during cell entry. Activation of ERK1/2 has also been observed between 5 and 45 min p.i. in peritoneal exudative macrophage infected with MHV-3 ([@bib52]). Although [@bib2] did not detect ERK1/2 activation after 2 h p.i., they did not perform the same experiments at earlier time points.

Despite different mechanisms for Egr-1 induction by diverse groups of viruses as discussed above, the finding that Egr-1 is up-regulated by these different viruses may suggest that infections by these viruses may have some common consequences on both viruses and host cells. One of the potential consequences is to facilitate virus replication in the host cells. Indeed, knockdown of Egr-1 by siRNA significantly impaired MHV propagation ([Fig. 6](#fig6){ref-type="fig"}B). It has also been reported that there is a good correlation between Egr-1 and viral RNA expressions in the mouse brains infected with Rabies and Borna disease viruses, which raises the possibility that Egr-1 expression may induce some phenotypic changes in neurons that render them more susceptible to viral replication ([@bib23]). The other potential consequence of Egr-1 induction is to promote host cell proliferation and survival. It has been suggested that the induction of Egr-1 expression in EBV-infected B lymphocytes, in EBV-transformed lymphoma and in HTLV-transformed cell lines, may facilitate cell growth and may play a role in tumorigenesis ([@bib9], [@bib24], [@bib59]). It has also been suggested that the expression of Egr-1 may change the phenotype of the infected cells, which may help KHSV to establish latency ([@bib67]). By analogy, the induction of Egr-1 by MHV infection may also facilitate the survival of the infected cells, thereby promoting the establishment of MHV persistence in glial cells. In support of this hypothesis is our finding that over-expression of Egr-1 suppresses the expression of the pro-apoptotic gene BNip3 ([Fig. 5](#fig5){ref-type="fig"}) that is down-regulated by MHV infection as demonstrated in our previous study ([@bib8]), whereas knockdown of Egr-1 leads to apoptosis when cells are infected with MHV ([Fig. 6](#fig6){ref-type="fig"}C).

The induction of Egr-1 expression by MHV infection may also contribute to viral pathogenicity. Both JHM and A59 are able to cause acute encephalitis and demyelination and persistence in the CNS, whereas MHV-2 cannot. Recent studies from our laboratory and others suggest that the ability of MHV strains to cause acute encephalitis is correlated with their ability to induce proinflammatory cytokines, particularly TNF-α and IL-6, in primary mouse astrocytes and microglia ([@bib44], [@bib77]). Interestingly, an Egr-1 binding site has been found in the TNF-α promoter region; it has also been shown that lipopolysaccharide (LPS)-induced expression of TNF-α was mediated through the activation of Egr-1 by ERK1/2 in macrophage ([@bib40], [@bib64]). Our most recent study indicated that infection of primary mouse astrocytes with JHM also induced Egr-1 expression (Cai and Zhang, unpublished results). It remains to be seen whether Egr-1 is involved in regulation of TNF-α induction by MHV infection in these cells. In addition, it has been shown previously that there is a general correlation between MHV persistence and demyelination disease in the mouse CNS ([@bib18]), which is also correlated with the ability of MHV strains to induce Egr-1 expression as found in this study. However, a firm establishment of such a correlation requires further extensive experimentations in animals, i.e. using Egr-1 gene-knockout mice. Nevertheless, our current observation may offer some interesting clues for future investigation on the mechanism by which signal transduction pathways are differentially regulated by MHV strains.

Materials and methods
=====================

Viruses, cells, antibodies, and reagents
----------------------------------------

MHV strain JHM ([@bib49]) was used throughout this study. In some experiments, MHV-A59 and MHV-2 strains were also used. These viruses were kindly provided by Dr. Michael Lai, and were propagated in the mouse astrocytoma DBT cell line ([@bib31]). DBT cells were also used for plaque assay and all other experiments involving cell culture throughout this study. DBT cells were cultured in 1× minimum essential medium (MEM) containing 7.5% newborn calf serum (NCS) (Gibco), 10% trypton phosphate broth (TPB) and 1 mM of penicillin and streptomycin. Antibodies specific to mouse Egr-1 protein and β-actin were purchased from Santa Cruz Biochem. and Sigma, respectively. Antibodies specific to total ERK1/2 and phosphorylated ERK1/2 were ordered from Cell Signaling. MEK inhibitor UO126 was purchased from Cell Signaling, Inc. JNK inhibitor SP600125 and p38 inhibitor SB203580 were purchased from Calbiochem. ERK inhibitor CI-1040 was a gift of Pfizer, Inc. The siRNA specific to Egr-1 (Egr-1-siRNA) (Cat.\# 040286-00) and to enhanced green fluorescence protein (EGFP-siRNA) (Cat.\# 46-0926) were purchased from Dharmocon, Inc. and Invitrogen, respectively.

Reverse transcription and polymerase chain reaction (RT-PCR)
------------------------------------------------------------

For detection of Egr-1 mRNAs, DBT cells were infected with MHV-JHM at a multiplicity of infection (m.o.i.) of 5, or mock-infected with serum-free medium. At various time points post-infection (p.i.), intracellular total RNAs were isolated and purified with the Trizol reagent (Invitrogen) according to the protocol from the manufacturer. RNAs were then treated with RNase-free DNase I (Promega) to remove the contaminated genomic DNAs. The concentrations of the RNA samples were determined by spectrophotometry (Hitatchi, Model 2100). Maloney murine leukemia virus (MMLV) reverse transcriptase (Promega) was used to reverse-transcribe the RNAs into cDNAs with a random hexomer oligonucleotide primer (Invitrogen) in a standard RT reaction as described previously ([@bib78]). cDNAs were then used as templates for PCR amplification with two pairs of primers specific for Egr-1 gene and β-actin gene (as an internal control), respectively. The sense primer for Egr-1 (5′Egr-1RT: 5′-ATG GCA GCG GCC AAG GCC-3′) corresponds to a sequence at nucleotide (nt) 1--18 of the open reading frame (ORF), and the anti-sense primer (3′Egr-1-RT: 5′-GGG TAC GGT TCT CCA GAC CCT-3′) is complementary to a sequence at nt 818--838 according to the published sequence (GenBank accession number: [NM007913](NM007913)). The PCR product is 838 nt in length. The primer pair for β-actin is 5′mb-actin (5′-ACC AAC TGG GAC GAT ATG GAG AAG A-3′, corresponding to the sequence at nt 229--253) and 3′mb-actin (5′-TAC GAC CAG AGG CAT ACA GGG ACA-3′, complementary to a sequence at nt 418--442 of the β-actin gene) (GenBank accession number: [NM007393](NM007393)). The PCR product for the β-actin gene is 214 nt in length. PCR was carried out in a reaction of 20 μl containing 1× PCR buffer (20 mM Tris--HCl, pH 8.3, 25 mM KCl, 1.5 mM MgCl~2~, 0.1% Tween-20), 200 μM each of the four dNTPs, 20 pM of primers, 3 U of Taq DNA polymerase, and 2 μl of the RT products as templates for 30 cycles with each cycle consisting of denaturing at 95 °C for 20 s, annealing at 55 °C for 1 min, and extension at 72 °C for 1 min with a final extension of 10 min. PCR was performed in a thermocycler DNA Engine (Model PTC-200, MJ Research). PCR products were analyzed by agarose gel electrophoresis, and the gels were stained with ethidium bromide and photographed with a UVP gel document center.

UV inactivation of MHV
----------------------

MHV-JHM strain was exposed to UV light for 20 min on ice in a UV-crosslinker (Fisher Scientific). Inactivation was confirmed by titration of samples in DBT cells before and after UV--light exposure, and by the absence of cytopathic effect after inoculation of DBT cell monolayers with UV-irradiated virus.

Western blot analysis
---------------------

DBT cells were grown to monolayer in 60-mm Petri dishes and were infected with MHV strains JHM, A59, or MHV-2 or mock-infected with serum-free medium. At different time points p.i., cells were harvested and lysed in 50 μl of strong lysis buffer (25 mM HEPES, pH 7.5, 0.5% sodium deoxycholate, 1% Triton X-100, 0.2% SDS, 5 mM EDTA, 1 mM Na~3~VO~4~, 20 mM β-glycerophosphate, 50 mM NaF) containing protease inhibitor cocktail tablets (Roche). The lysates were sonicated 3 times for 20 s each on ice. The protein concentration was measured by using Bio-Rad protein assay kit (Bio-Rad, CA). Equal amounts of cell lysates were boiled for 5 min, chilled on ice, and pelleted by centrifugation before loading onto gels. Proteins were separated by SDS-polyacrylamide gel (10%) electrophoresis (PAGE). The proteins were then transferred to nitrocellulose membrane (MSI, Westborough, MA) for 7 h at 40 V in a transfer buffer (25 mM Tris, 200 mM glycine, 20% methanol, 0.02% SDS). After being blocked with 5% skim milk in Tris-buffered saline (TBS) for 1 h at room temperature (RT), the membrane was washed three times in TBS containing 0.5% Tween-20 and immunoblotted with a primary antibody (1 μg/ml) for 2 h at RT, followed by a secondary antibody coupled to horseradish peroxidase (1:1000 dilution) (Sigma) for 1 h at RT. The presence of the interested protein was detected by enhanced chemiluminescence (ECL) using peracid as a substrate (Amersham) followed by autoradiography.

Construction of plasmid DNA
---------------------------

For cloning of the Egr-1 gene, RNAs were isolated from DBT cells and cDNAs were synthesized by RT using the random hexomer primer as described above. The Egr-1 gene was amplified by PCR using the sense primer 5′Egr-1ORF (5′-TTT *GAA TTC* GGG ATG GCA GCG GCC AAG G-3′, corresponding to the first 16 nt of the Egr-1ORF, GenBank accession number [NM007913](NM007913)), which contains an *Eco*RI site at the 5′-end (underlined), and the anti-sense primer 3′Egr-1ORF (5′-TTT *CTC GAG* GCA AAT TTC AAT TGT CCT GGG-3, complementary to the last 21 nt of the Egr-1 ORF), which contains an *Xho*I site (underlined). The PCR products were directly cloned into pCR2.1 TA cloning vector (Invitrogen), resulting in pTA-Egr-1. The sequence of the clone was confirmed by automatic DNA sequencing (IBI, Prizm-377) in the Departmental Core Facility. pTA-Egr-1 DNA was then digested with *Eco*RI and *Xho*I and directionally cloned into the *Eco*RI and *Xho*I sites of the plasmid pcDNA3 (Invitrogen), generating pcDNA3/Egr-1. To generate pBS-CMV-Egr-1 plasmid, the pcDNA3/Egr-1 DNA was digested with *Eco*RI and *Xba*I and directionally cloned into the *Eco*RI and *Xba*I sites of the plasmid pBS-CMV.

DNA transfection and assays for luciferase and beta-galactosidase activities
----------------------------------------------------------------------------

For DNA transfection, the LipofectAmine reagent was used according to the manufacturer\'s instruction (Invitrogen). Briefly, DBT cells were seeded in a 24-well culture plates at a density of 4 × 10^5^ cells per well. When the cells reached to approximately 60% confluency, ≈ 500 ng of plasmid DNAs and 3 μl of the LipofectAmine reagent were diluted separately in 100 μl of serum-free OPTI medium without antibiotics, mixed, and incubated at RT for 30 min before adding to each well of the 24-well plate. DBT cells were washed with PBS and 300 μl of OPTI medium was added to each well of the cell culture. The DNA-lipofectAmine mixture (200 μl) was added to each well and the cell culture plates were incubated at 37 °C for various time periods as indicated. For luciferase assay, cells were harvested along with culture medium and lysed by freezing and thawing. The cell lysate (100 μl) was assayed for luciferase activity using the luciferase assay system (Promega) in a microtiter plate luminometer (Dynex Technologies). For β-galactosidase assay, the medium was removed and the monolayers were washed twice with PBS after 24 h post-transfection. The cells were harvested into microfuge tubes by scraping the cells. The cells were recovered by centrifugation at 12,000×*g* for 10 s at RT. 125 μl lysis buffer (0.25 M Tris--HCl, pH 8.0) was added into the tubes. The cells were lysed by freezing at − 70 °C and thawing at 37 °C three times. The cell extract was recovered by centrifuging at 12,000×*g* for 5 min at 4 °C. For each sample to be assayed, the following reagents were mixed together: 3 μl of 100× Mg solution (0.1 M MaCl2, 4.5 M β-mercaptoethanol), 66 μl of 1× ONPG (*o*-nitrophenyl-β-[d]{.smallcaps}-galactopyranoside), 30 μl of cell extract and 201 μl of 0.1 M sodium phosphate (pH 7.5). The reaction was incubated at 37 °C for 30 min. The reaction was then stopped by adding 500 μl of 1 M Na~2~CO~3~. The optical density of the reaction was read at a wavelength of 420 nm.

Detection of apoptotic cells
----------------------------

Apoptosis was determined by counting the apoptotic nuclei under a microscope following propidium iodide staining as described previously ([@bib46]). Apoptosis was expressed as mean percentage of the cell population and standard deviation of three independent experiments.

Statistical analysis
--------------------

The results are expressed as mean ± standard deviation (SD) and the mean values were compared using Student\'s *t* test. Values of *p*  \< 0.05, *p*  \< 0.01, and *p*  \< 0.001 were considered statistically significant.

This work was supported by grants from the National Institutes of Health (AI47188 and NS47499). We thank Dr. Sebolt-Leopold (Pfizer, Inc.) for kindly providing the inhibitor CI-1040, and Kelli Halcom (Zhang\'s laboratory) for proofreading the manuscript.
